Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Conditions
Interventions
None listed
Sponsors
Sun Pharmaceutical Industries Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged �18 years. 2. EMR data (age, gender, diagnosis, co-morbidities, concomitant medication, PPIs dose and duration) of GERD patients prescribed with PPIs. 3. Patients with at least two visits to the clinic after the baseline visit will be included. 4. Patients with follow-up duration of at least 4 weeks after the baseline visit will be included.
Exclusion criteria
Exclusion criteria: 1. GERD patient with non-compliance to the treatment as per physician discretion. 2. Patient diagnosed with achalasia, eosinophilic esophagitis, infectious esophagitis, gastroparesis, esophageal stricture, and cancer.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. Prescription patterns of PPIs 2. Management of GERD patients with partial or non-responseââ?¬â?¢ to standard doses of PPIsTimepoint: 1. Baseline 2. Two Follow-up visit in 12 months duration from the baseline visit | — |
Primary
| Measure | Time frame |
|---|---|
| To estimate the burden and understand the clinical profile of Gastroesophageal reflux disease (GERD) patients with partial-response to standard doses of proton pump inhibitors (PPIs)Timepoint: 1. Baseline 2. Two Follow-up visit in 12 months duration from the baseline visit | — |
Countries
India
Contacts
Public ContactDr Srivani Palukuri
THB c/o Sekhmet Technologies Pvt Ltd.
Outcome results
None listed